Pharmicell Co.,Ltd. Logo

Pharmicell Co.,Ltd.

Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.

005690 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로 874 (신사동, 쌍봉빌딩 7층), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology. The company is a pioneer in the field, having developed and commercialized Hearticellgram®-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its business is diversified across four main segments: stem cell therapeutics, including ongoing research for conditions like liver disease; a biochemical division that conducts oligonucleotide synthesis and produces nucleosides, mPEGs, and pharmaceutical intermediates; a stem cell banking business for adult and cord blood ('Twelve' brand); and a line of cosmetics derived from stem cell culture media ('By Pharmicell lab' brand).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Pharmicell Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-21 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 7.6 KB
2025-08-13 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.0 MB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 779.0 KB
2025-07-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.2 KB
2025-07-08 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmicell Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Pharmicell Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan 4553
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan 4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye TRILC
UCB Logo
UCB
Biopharma firm developing treatments for severe neurological and immunological diseases.
Belgium UCB
Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.
Hong Kong N/A
UNION KOREA PHARM CO.,Ltd Logo
Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.
South Korea 080720
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel UNVO-M
Valbiotis Logo
Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.
France ALVAL
Valneva SE Logo
Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.
France VLA
Vaxcell-Bio Therapeutics Logo
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
South Korea 323990

Talk to a Data Expert

Have a question? We'll get back to you promptly.